A detailed history of Venturi Wealth Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 185 shares of CTLT stock, worth $10,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185
Previous 236 21.61%
Holding current value
$10,915
Previous $13,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$56.16 - $60.96 $2,864 - $3,108
-51 Reduced 21.61%
185 $11,000
Q2 2024

Jul 19, 2024

BUY
$53.58 - $57.02 $9,751 - $10,377
182 Added 337.04%
236 $13,000
Q1 2024

Apr 23, 2024

BUY
$42.56 - $59.82 $383 - $538
9 Added 20.0%
54 $3,000
Q1 2023

May 02, 2023

BUY
$45.44 - $74.26 $2,044 - $3,341
45 New
45 $2,000
Q3 2019

Oct 29, 2019

BUY
$47.45 - $58.05 $8,161 - $9,984
172 New
172 $8,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Venturi Wealth Management, LLC Portfolio

Follow Venturi Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.